Insulin Family advanced
Insulin Analogue Immunogenicity
Risk of anti-drug antibody formation against insulin analogues and clinical implications.
By Encyclopeptide Editorial | 1 min read
insulin immunogenicity anti-drug-antibodies ADA diabetes
Overview
All insulin products can elicit anti-drug antibodies, though modern recombinant insulins and analogues generally produce lower immunogenicity than older animal-derived preparations.
Immunogenicity Rates
| Insulin Type | ADA Incidence | Clinical Significance |
|---|---|---|
| Animal insulin | 30-50% | High |
| Human recombinant | 5-15% | Low-Moderate |
| Insulin analogues | 2-10% | Low |
Clinical Consequences
- Insulin resistance: High-titer ADAs can neutralize insulin action
- Allergic reactions: Local or systemic hypersensitivity
- Lipodystrophy: Immune-mediated injection site reactions
Chemical Identity
| Property | Value |
|---|---|
| Name | Insulin Analogue Immunogenicity |
| Category | Insulin Family |
References
- Encyclopeptide Database. “Insulin Analogue Immunogenicity” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Insulin Analogue Immunogenicity with interactive quizzes on Wikipept.
Take a Quiz on Wikipept